Inhibition of CXCR2 plays a pivotal role in re-sensitizing ovarian cancer to cisplatin treatment-Reference-Cited by-同舟云学术

Inhibition of CXCR2 plays a pivotal role in re-sensitizing ovarian cancer to cisplatin treatment

Published:2021-05-26 Issue:10 Volume:13 Page:13405-13420
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Henriques Taciane Barbosa¹,dos Santos Diandra Zipinotti¹,dos Santos Guimarães Isabella²,Tessarollo Nayara Gusmão¹,Lyra-Junior Paulo Cilas Morais¹,Mesquita Patricia³⁴,Pádua Diana³⁴,Amaral Ana Luisa³⁴,Cavadas Bruno³⁴,Pereira Luisa³⁴,Silva Ian Victor⁵⁶⁷,Almeida Raquel Maria da Silva Graça³⁴⁸,Rangel Leticia Batista Azevedo¹⁶⁷

Affiliation:

1. Biotechnology Program/RENORBIO, Health Sciences Center, Federal University of Espirito Santo, Espirito Santo, Brazil

2. Translational Research Laboratory/Division of Clinical Research and Technological Development/National Cancer Institute (INCa), Rio de Janeiro, Brazil

3. Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, Porto, Portugal

4. Institute of Pathology and Molecular Immunology (IPATIMUP), University of Porto, Porto, Portugal

5. Department of Morphology, Health Sciences Center, Federal University of Espirito Santo, Espirito Santo, Brazil

6. Biochemistry and Pharmacology Program, Federal University of Espirito Santo, Espirito Santo, Brazil

7. Pharmaceutical Sciences Department, Health Sciences Center, Federal University of Espirito Santo, Espirito Santo, Brazil

8. Biology Department, Faculty of Sciences, University of Porto, Porto, Portugal

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-omics differences in the bone marrow between essential thrombocythemia and prefibrotic primary myelofibrosis;Clinical and Experimental Medicine;2024-07-08

2. Leveraging human–mouse studies to advance the genetics of hearing impairment in Africa;The Journal of Gene Medicine;2024-07

3. Harnessing neutrophil plasticity for HCC immunotherapy;Essays in Biochemistry;2023-09

4. Drug Repurposing for Targeting Myeloid-Derived Suppressor-Cell-Generated Immunosuppression in Ovarian Cancer: A Literature Review of Potential Candidates;Pharmaceutics;2023-06-22

5. Atorvastatin improves cisplatin sensitivity through modulation of cholesteryl ester homeostasis in breast cancer cells;Discover Oncology;2022-12-08